Cannabis & immune system: CB2 receptors & inflammation

The immune system and the endocannabinoid system

The endocannabinoid system (ECS) is deeply integrated into immune regulation. CB2 receptors – unlike CB1, which is hardly present in the brain – are mainly found on immune cells: B cells, T cells, natural killer cells, macrophages, mast cells and dendritic cells. CB2 activation by cannabinoids modulates inflammatory reactions bidirectionally.

CB2 receptors on immune cells

Anti-inflammatory mechanisms of cannabinoids

CBD main mechanisms:
– TRPV1 activation and desensitization → reduced mast cell activation
– COX-2 inhibition → less prostaglandin production
– NF-κB inhibition → less pro-inflammatory gene expression
– PPARγ activation → anti-inflammatory transcription
– Adenosine reuptake inhibition → increased adenosine → A2A receptor activation = anti-inflammatory

THC via CB2: CB2 activation → cAMP reduction → PKA inhibition → NF-κB suppression → less TNF-α, IL-1β, IL-6.

Autoimmune diseases: Cannabis as an immunomodulator

In autoimmune diseases, the immune system attacks the body’s own tissue – the excessive Th1/Th17 activation is often central. Cannabis can have a modulatory effect here through CB2-mediated Th1→Th2 shift:

Multiple sclerosis: Sativex approved for spasticity (CB1); experimental: CBD reduces neuroinflammation and Th17 activation in animal models (Kozela et al. 2011)

Rheumatoid arthritis: Blake et al. 2006 (Rheumatology): Nabiximols-RCT, n=58. Significant reduction in pain intensity and DAS28 score (disease activity). CB2 on synoviocytes directly affected.

Crohn’s disease: Naftali et al. 2013 (Clin Gastroenterol Hepatol): Cannabis smoking vs. placebo, n=21. 45 % complete remission vs. 10 % placebo. CB2 on intestinal immune cells regulates intestinal inflammation.

Immunosuppression vs. immunomodulation: the difference

Cannabis is not a classic immunosuppressant (like methotrexate or ciclosporin). It modulates – regulates the immune response adaptively:
– In case of excess (autoimmunity): rather immunosuppressive
– In case of deficit (infection defense): little impairment

Chronic, high-dose THC consumption can reduce NK cell activity and T cell proliferation – clinically relevant in immunocompromised patients (HIV, chemotherapy). Low doses of CBD hardly have this effect.

FAQ: Cannabis and the immune system

Summary

CB2 receptors on immune cells make the ECS a central immune regulator. Cannabis – especially CBD – has an anti-inflammatory effect via COX-2 inhibition, NF-κB suppression and CB2-mediated Th1→Th2 shift. There are positive clinical data for autoimmune diseases (MS, arthritis, Crohn’s disease). Not an immunosuppressant substitute, but a useful symptomatic supplement. Entourage effect for the synergy of all cannabis ingredients; ECS foundations for the overall picture.